Relationship between Traditional Chinese Medicine Syndrome Elements and Prognosis of Patients with IgA Nephropathy
暂无分享,去创建一个
Weiguang Zhang | Z. Dong | Ying Zheng | S. Duan | Ping Li | Z. Yin | Jianghua Ke | Linchang Liu | Xiangmei Chen | Yilun Qu | Shuang Li | Yujing Ke | Jinshi Yao | Shuwei Duan | Zheyi Dong
[1] B. Rovin,et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.
[2] Qiang Wan,et al. Huangqi Guizhi Wuwu Decoction attenuates Podocyte cytoskeletal protein damage in IgA nephropathy rats by regulating AT1R/Nephrin/c-Abl pathway. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] S. Shah,et al. Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience , 2021, PloS one.
[4] K. Nitta,et al. Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy , 2021, Scientific Reports.
[5] Jiaxing Tan,et al. Sex disparities in IgA nephropathy: a retrospective study in Chinese patients , 2020, International Urology and Nephrology.
[6] Jing Ma,et al. Epidemiology and risk factors for progression in Chinese patients with IgA nephropathy. , 2020, Medicina clinica.
[7] Hong Zhang,et al. External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian Cohort , 2020, Kidney international reports.
[8] Zhangsuo Liu,et al. External Validation of the International IgA Nephropathy Prediction Tool. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[9] Jia Zhang,et al. A Microcosmic Syndrome Differentiation Model for Metabolic Syndrome with Multilabel Learning , 2020, Evidence-based complementary and alternative medicine : eCAM.
[10] Limin Liu,et al. Renal survival and risk factors in IgA nephropathy with crescents , 2020, International Urology and Nephrology.
[11] Shen Li,et al. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial , 2020, Trials.
[12] Keiichi Matsuzaki,et al. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. , 2019, JAMA internal medicine.
[13] Xiangmei Chen,et al. Potential Association of Body Constitution with the Prognosis of IgA Nephropathy: A Long-Time Follow-Up of 203 Cases in China , 2019, Evidence-based complementary and alternative medicine : eCAM.
[14] Z. Su,et al. Association between lifestyle, gender and risk for developing end-stage renal failure in IgA nephropathy: a case-control study within 10 years , 2019, Renal failure.
[15] P. Fu,et al. Analysis of the relationship between Oxford classification, IgM deposition and multiple indexes and the adverse prognosis of patients with primary IgA nephropathy and related risk factors , 2018, Experimental and therapeutic medicine.
[16] C. Xiaojun,et al. Traditional Chinese Medicine syndrome elements of male infertility revealed by latent tree model analysis , 2018, Journal of Traditional Chinese Medicine.
[17] F. Schena,et al. Epidemiology of IgA Nephropathy: A Global Perspective. , 2018, Seminars in nephrology.
[18] L. Tang,et al. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria , 2018, Kidney and Blood Pressure Research.
[19] Mark Haas,et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. , 2017, Kidney international.
[20] Youming Peng,et al. Tubular atrophy/interstitial fibrosis scores of Oxford classification combinded with proteinuria level at biopsy provides earlier risk prediction in lgA nephropathy , 2017, Scientific Reports.
[21] Xuefeng Sun,et al. Abelmoschus manihot – a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial , 2017, Trials.
[22] Peng Xie,et al. The new Asian modified CKD-EPI equation leads to more accurate GFR estimation in Chinese patients with CKD , 2016, International Urology and Nephrology.
[23] J. Novak,et al. IgA nephropathy , 2016, Nature Reviews Disease Primers.
[24] Junping Wei,et al. Analysis of TCM syndrome elements and relevant factors for senile diabetes , 2013 .
[25] C. Zeng,et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[26] B. Kasiske,et al. KDIGO Clinical Practice Guideline for Glomerulonephritis , 2012 .
[27] L. Thibaudin,et al. Predicting the risk for dialysis or death in IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[28] A. McGrogan,et al. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[29] He Li-qun. Correlativity between Chinese medical syndromes and clinical prognosis of IgA nephropathy , 2010 .
[30] Wang Dao-cheng. The relation between the level of hemoglobin and differentiation of TCM in chronic heart failure and clinical effect , 2008 .
[31] J. Scholey,et al. Remission of proteinuria improves prognosis in IgA nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.
[32] Zhu Yan-bo. Study on the Related Influencing Factors of Yang-deficiency Constitution in Chinese Medicine , 2007 .
[33] Xiang-mei Chen,et al. [A multi-centeric epidemiological survey on TCM syndrome in 1016 patients with IgA nephropathy and analysis of its relevant factors]. , 2006, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[34] Z. Zhang. The induction of syndrome factor and affecting target , 2006 .
[35] D. Bao. The Relationship between Syndrome Differentiation of Traditional Chinese Medicine and the Degree of Pathological Changes in IgA Nephropathy Patients , 2004 .